Exelon and Bristol Myers Squibb Outperform in Mixed Trading Session

Key Facts

1EXC rose 3.50% to $47.88 on Thursday, outperforming peers after a three-day losing streak.

2BMY rose 4.16% to $58.13 on Thursday, ending a two-day losing streak.

3The S&P 500 was mostly unchanged, while the Dow Jones Industrial Average rose 1.14%.

Amid a divergence in major index performance, large-cap stocks showed notable strength during Thursday's session. EXC shares rose 3.50% to $47.88, outperforming sector peers and snapping a three-day losing streak. Similarly, BMY climbed 4.16% to close at $58.13, ending two days of declines, while the S&P 500 remained mostly flat compared to a 1.14% gain in the Dow Jones Industrial Average.

This upward move represents a technical reversal following recent selling pressure, with both stocks displaying relative strength within the utilities and healthcare sectors. Per market data, BMY had closed at $56.44 on July 1, 2026, indicating a swift shift in investor sentiment. Likewise, EXC recovered from its July 1 level of $46.26, supported by selective buying in defensive large-cap names.

Traders should watch for sustained momentum above recent levels, noting that BMY closed at $56.44 and EXC at $46.26 (as of July 1, 2026) prior to the latest rally. Looking ahead, global risk appetite may be influenced by upcoming economic catalysts, including the Chinese Manufacturing PMI data scheduled for June 30, which serves as a key barometer for global growth and large-cap equity flows.